Evidence map›Paper›PMID 32810965›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2020

[Analysis of gene mutations and clinic features in 108 patients with myeloproliferative neoplasm].

Y X Tan, N Xu, J X Huang, W E Wu, L Liu, L L Zhou, X L Liu, C X Yin, D Xu, X Zhou

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Y X TanDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
N XuDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
J X HuangDepartment of Hematology, Yuebei People's Hospital, Shaoguan 512025, China.
W E WuDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
L LiuDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
L L ZhouDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
X L LiuDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
C X YinDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
D XuDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
X ZhouDepartment of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou 510515, China.
Southern Medical University · CNShantou University · CN

Funding

Dean of Southern Hospital of Southern Medical University 2016A002Guangdong Provincial Medical Research 201611917123790Guangzhou Science and Technology Plan 201904010488National Natural Science Foundation of China 81700104Natural Science Foundation of Guangdong 2017A030313506
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Myeloproliferative DisordersPolycythemia VeraCalreticulinHumansJanus Kinase 2MutationCalreticulinJanus Kinase 2ASXL1Driver geneJAK2Myeloproliferative neoplasmNext-generation sequencing

Identifiers

PMID32810965
PMCPMC7449771
OpenAlexW3081116410

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.